Regeneron Pharmaceuticals (REGN) Free Cash Flow Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 31.42% |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.65% |
| Dec 31, 2025 | -16.22% |
| Sep 30, 2025 | 33.13% |
| Jun 30, 2025 | 42.75% |
| Mar 31, 2025 | -25.34% |
| Dec 31, 2024 | -21.73% |
| Sep 30, 2024 | -35.35% |
| Jun 30, 2024 | -8.41% |
| Mar 31, 2024 | 32.42% |
| Dec 31, 2023 | -7.80% |
| Sep 30, 2023 | 55.68% |
| Jun 30, 2023 | 11.42% |
| Mar 31, 2023 | 31.10% |
| Dec 31, 2022 | 34.22% |
| Sep 30, 2022 | 3.75% |
| Jun 30, 2022 | 63.67% |
| Mar 31, 2022 | 33.56% |
| Dec 31, 2021 | 51.06% |
| Sep 30, 2021 | 111.51% |
| Jun 30, 2021 | 15.70% |
| Mar 31, 2021 | 3.25% |
| Dec 31, 2020 | 32.55% |
| Sep 30, 2020 | -46.55% |
| Jun 30, 2020 | 125.87% |
| Mar 31, 2020 | 20.01% |
| Dec 31, 2019 | 39.28% |
| Sep 30, 2019 | -6.47% |
| Jun 30, 2019 | -28.90% |
| Mar 31, 2019 | 151.56% |
| Dec 31, 2018 | 83.54% |
| Sep 30, 2018 | -22.57% |
| Jun 30, 2018 | 150.69% |
| Mar 31, 2018 | 65.08% |
| Dec 31, 2017 | 78.59% |
| Sep 30, 2017 | 61.35% |
| Jun 30, 2017 | -32.41% |
| Mar 31, 2017 | 207.38% |
| Dec 31, 2016 | 4.09% |
| Sep 30, 2016 | 106.17% |
| Jun 30, 2016 | 40.64% |
| Mar 31, 2016 | -42.75% |
| Dec 31, 2015 | 10.07% |
| Sep 30, 2015 | 293.92% |
| Jun 30, 2015 | 29.99% |
| Mar 31, 2015 | -30.07% |
| Dec 31, 2014 | 49.01% |
| Sep 30, 2014 | 52.12% |
| Jun 30, 2014 | 95.12% |
| Mar 31, 2014 | 29.87% |
| Dec 31, 2013 | 69.96% |
| Sep 30, 2013 | -24.18% |
| Jun 30, 2013 | 67.76% |
| Mar 31, 2013 | 58.90% |
| Dec 31, 2012 | 46.36% |
| Sep 30, 2012 | 26.76% |